291 related articles for article (PubMed ID: 33182685)
1. Optimal Clinical Management and the Molecular Biology of Angiosarcomas.
Chen TW; Burns J; Jones RL; Huang PH
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182685
[TBL] [Abstract][Full Text] [Related]
2. Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?
Azzariti A; Porcelli L; Mangia A; Saponaro C; Quatrale AE; Popescu OS; Strippoli S; Simone G; Paradiso A; Guida M
Exp Cell Res; 2014 Feb; 321(2):240-7. PubMed ID: 24384475
[TBL] [Abstract][Full Text] [Related]
3. Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution.
Florou V; Rosenberg AE; Wieder E; Komanduri KV; Kolonias D; Uduman M; Castle JC; Buell JS; Trent JC; Wilky BA
J Immunother Cancer; 2019 Aug; 7(1):213. PubMed ID: 31395100
[TBL] [Abstract][Full Text] [Related]
4. Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features.
Ronchi A; Cozzolino I; Zito Marino F; De Chiara A; Argenziano G; Moscarella E; Pagliuca F; Franco R
Ann Diagn Pathol; 2020 Oct; 48():151597. PubMed ID: 32829071
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study.
Veiga LHS; Vo JB; Curtis RE; Mille MM; Lee C; Ramin C; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Lancet Oncol; 2022 Nov; 23(11):1451-1464. PubMed ID: 36240805
[TBL] [Abstract][Full Text] [Related]
6. [Rare tumors: Angiosarcoma].
El-Ghazzi N; Bay JO
Bull Cancer; 2023 May; 110(5):581-588. PubMed ID: 36973135
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).
Versleijen-Jonkers YMH; Hillebrandt-Roeffen MHS; Weidema ME; Mooren J; von Rhein DT; de Bitter TJJ; Kroeze LI; Desar IME; Flucke UE
Sci Rep; 2023 Feb; 13(1):2653. PubMed ID: 36788310
[TBL] [Abstract][Full Text] [Related]
8. Current and Future Directions for Angiosarcoma Therapy.
Florou V; Wilky BA
Curr Treat Options Oncol; 2018 Mar; 19(3):14. PubMed ID: 29520447
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
[TBL] [Abstract][Full Text] [Related]
10. Current Management of Angiosarcoma: Recent Advances and Lessons From the Past.
Florou V; Wilky BA
Curr Treat Options Oncol; 2021 Jun; 22(7):61. PubMed ID: 34097172
[TBL] [Abstract][Full Text] [Related]
11. Angiosarcoma.
Young RJ; Brown NJ; Reed MW; Hughes D; Woll PJ
Lancet Oncol; 2010 Oct; 11(10):983-91. PubMed ID: 20537949
[TBL] [Abstract][Full Text] [Related]
12. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
Ravi V; Subramaniam A; Zheng J; Amini B; Trinh VA; Joseph J; Mennel RG; Bishop AJ; Sturgis EM; Goepfert RP; Yalamanchili S; Botello G; Stephen B; Piha-Paul SA; Patel AB; Lazar AJ; Conley AP; Benjamin RS; Patel SR; Futreal PA; Somaiah N; Naing A
Cancer; 2022 Sep; 128(18):3383-3391. PubMed ID: 35792683
[TBL] [Abstract][Full Text] [Related]
13. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study.
Constantinidou A; Sauve N; Stacchiotti S; Blay JY; Vincenzi B; Grignani G; Rutkowski P; Guida M; Hindi N; Klein A; Thibaud V; Sufliarsky J; Desar I; Steeghs N; Litiere S; Gelderblom H; Jones RL
ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32847839
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Molecular Insights of Radiation-Induced Breast Sarcomas: Is There Hope on the Horizon for Effective Treatment of This Aggressive Disease?
Kokkali S; Moreno JD; Klijanienko J; Theocharis S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456944
[TBL] [Abstract][Full Text] [Related]
16. Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma.
Kurisetty V; Bryan BA
Angiol Open Access; 2013 Apr; 1():. PubMed ID: 25374893
[TBL] [Abstract][Full Text] [Related]
17. Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitative analysis of survival.
Kruse AJ; Sep S; Slangen BF; Vandevijver NM; Van Gorp T; Kruitwagen RF; Van de Vijver KK
Int J Gynecol Cancer; 2014 Jan; 24(1):4-12. PubMed ID: 24257655
[TBL] [Abstract][Full Text] [Related]
18. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
[TBL] [Abstract][Full Text] [Related]
19. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
[TBL] [Abstract][Full Text] [Related]
20. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
